Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Enteris BioPharma | Contract Pharma

What are you searching for?

Sign in

Search by

Enteris BioPharma

Company Headquarters

83 Fulton St. , Boonton, NJ, 07005, US

Driving Directions Phone: View Phone
View website

Request more information from Enteris BioPharma

Request more information from Enteris BioPharma

Categories from Enteris BioPharma

505(b)(2)
Analytical Methods Development
Drug Delivery Systems
Feasibility Studies
Filling, Capsule
Formulation Development
Formulation Services
Formulation, Controlled Release
Manufacturing, Cytotoxic & High Potency Compounds
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Microbial-based Therapeutic Proteins
Manufacturing, Nasal Delivery
Manufacturing, Tablets
Quality Control Testing
HPAPI Drug Solid Oral Dosage (Sod) Manufacturing – Power, Precision and Productivity

White Papers / Tech Papers

HPAPI Drug Solid Oral Dosage (Sod) Manufacturing – Power, Precision and Productivity

How to Ensure Your CDMO Partner Has the Experience and Expertise to Get Your HPAPI Product Across the Finish Line.

Released By Enteris BioPharma

Enteris BioPharma: Custom Solutions – From Bench to Market

Sponsored Content

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Released By Enteris BioPharma

Related Content

Collaborations & Alliances

Enteris BioPharma Receives $10M Milestone from Cara Therapeutics

Third milestone payment related to the development of Oral KORSUVA.

Breaking News

Enteris BioPharma Completes Expansion of Manufacturing Facility

Also launches CDMO business for the development and manufacture of difficult to formulate drugs and highly potent compounds.

Sponsored Content

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Released By Enteris BioPharma

Promotions & Moves

Enteris BioPharma Names CEO

35-year industry vet, Joel Tune, will take the company helm

Breaking News

Enteris BioPharma Launches Contract Manufacturing Ops

Will offer production of API using microbial expression systems